| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |